Everence Capital Management »

Supernus Pharmaceuticals shares owned by Everence Capital Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Everence Capital Management from 13F filings

Historical chart of Everence Capital Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Everence Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Everence Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $219k 7.6k 28.93
2023-09-30 $209k 7.6k 27.61
2023-06-30 $251k 7.6k 33.16
2023-03-31 $274k 7.6k 36.20
2022-12-31 $270k 7.6k 35.67
2022-09-30 $256k 7.6k 33.82
2022-03-31 $272k 8.4k 32.27
2021-06-30 $320k 10k 30.83
2021-03-31 $272k 10k 26.20
2020-12-31 $261k 10k 25.14
2020-09-30 $216k 10k 20.81
2020-06-30 $250k 10k 24.08
2020-03-31 $187k 10k 18.02
2019-06-30 $232k 7.0k 33.05
2019-03-31 $246k 7.0k 35.04
2018-06-30 $205k 3.4k 59.94